Rheumatology CME Courses
Rheumatology CME Courses
By CMEInfo
Credits: 25.5 (AMA PRA Category 1)
Format: Audio CD, MP3, MP4, Online Streaming Video
Price: $1,095
Release Date: May 15, 2020
Expiration Date: May 15, 2023
Summary:
Learn from the Experts
Key rheumatologic medicine topics are addressed in The Brigham Board Review in Rheumatology. Learn new strategies with this case-based online CME program as world-renowned faculty, led by Jonathan S. Coblyn, MD, Simon M. Helfgott, MD, and Paul F. Dellaripa, MD, help you to better:
- Apply current and recommended rheumatology guidelines in clinical practice
- Perform differential diagnoses of complex clinical presentations related to rheumatologic disorders
- Identify and apply current therapeutic options for specific rheumatologic disorders
- Evaluate and interpret current literature relevant to clinical practice in rheumatology
By ScientiaCME
Credits: 1.0 (AMA PRA Category 1)
Format: Online Streaming Video
Price: Free
Release Date: September 04, 2017
Expiration Date: September 04, 2019
Summary:
This is an online CME self-learning program.
Rheumatoid arthritis (RA) is a systemic autoimmune disorder in which joints, typically those in the hands and feet, become inflamed, swollen, painful, and stiff. Without appropriate treatment, the inflammation may become chronic and cause irreversible destruction of bone and cartilage in the affected joints as well as contribute to the development of clinically important co-morbid conditions with attendant morbidity and mortality. The National Arthritis Data Workgroup estimates that about 1.3 million U.S. adults (0.6% of the adult population) have RA. RA imposes a considerable disease burden. Patients with RA have substantially lower health-related quality of life (QOL) than the general population with lower overall scores for physical and mental health across all age groups.The RA disease burden also is associated with increased health care resource utilization. Notably, RA patients with low QOL are twice as likely to be hospitalized as RA patients with high QOL.
Some have suggested that criteria used for the past two decades are inadequate for addressing the disease burden of RA because by the time a physician detects rheumatoid nodules or radiographic erosion, the optimal time has passed for treatment initiation, representing a gap in care relating to diagnosis of disease. Another potential gap is illustrated by studies in which researchers demonstrated that a systematic, objective approach to therapy with Disease Activity Score-driven therapy yields superior outcomes to routine care.
Some have suggested that criteria used for the past two decades are inadequate for addressing the disease burden of RA because by the time a physician detects rheumatoid nodules or radiographic erosion, the optimal time has passed for treatment initiation, representing a gap in care relating to diagnosis of disease. Another potential gap is illustrated by studies in which researchers demonstrated that a systematic, objective approach to therapy with Disease Activity Score-driven therapy yields superior outcomes to routine care.
By the end of the session the participant will be able to:
- Describe the pathophysiology of RA such that it might inform treatment mechanisms.
- Describe professional guideline recommendations’ approaches to the diagnosis and treatment of RA and, where applicable, apply them to patient cases
- Identify the currently available and emerging pharmacotherapeutic treatments for management of RA and apply them to patient cases using evidence-based medicine.
- Evaluate a treatment plan for a specific patient with RA to optimize safety and efficacy, suggesting modifications for improvement, including the management of comorbidities.
- Describe the challenges and barriers to care associated with treating patients with RA.